These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population. Rasmussen S, Jensen TH, Henriksen SL, Haastrup PF, Larsen PV, Søndergaard J, Jarbøl DE. Scand J Gastroenterol; 2015 Feb; 50(2):162-9. PubMed ID: 25525975 [Abstract] [Full Text] [Related]
3. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Lee SY, Lee KJ, Kim SJ, Cho SW. Digestion; 2009 Feb; 79(3):196-201. PubMed ID: 19342860 [Abstract] [Full Text] [Related]
12. Self-rated health and functional capacity in individuals reporting overlapping symptoms of gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome - a population based study. Jarbøl DE, Rasmussen S, Balasubramaniam K, Elnegaard S, Haastrup PF. BMC Gastroenterol; 2017 May 18; 17(1):65. PubMed ID: 28521729 [Abstract] [Full Text] [Related]
13. Gastroesophageal reflux disease in a typical African population: a symptom-based multicenter study. Nwokediuko SC, Adekanle O, Akere A, Olokoba A, Anyanechi C, Umar SM, Maiyaki A, Ijoma U, Obienu O, Uhunmwangho A, Ndububa D. BMC Gastroenterol; 2020 Apr 15; 20(1):107. PubMed ID: 32293291 [Abstract] [Full Text] [Related]
16. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease. Mönnikes H, Schwan T, van Rensburg C, Straszak A, Theek C, Sander P, Lühmann R. Aliment Pharmacol Ther; 2012 Jun 15; 35(11):1279-89. PubMed ID: 22486552 [Abstract] [Full Text] [Related]